Showing results (761-770 of 804) with videos related to
Sort By:
Pageof 81
The Lancet. Microbe|December 4, 2023
Performance of clinical metagenomics in France: a prospective observational studyJacques Fourgeaud, Béatrice Regnault, Vichita Ok, et al.Journal of Developmental Origins of Health and Disease|September 21, 2020
Seeing the fetus from a DOHaD perspective: discussion paper from the advanced imaging techniques of DOHaD applications workshop held at the 2019 DOHaD World CongressJanna L Morrison, Oyekoya T Ayonrinde, Alison S Care, et al.JHEP Reports : Innovation in Hepatology|March 20, 2023
TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trialCyrille Féray, Loic Campion, Philippe Mathurin, et al.Frontiers in Immunology|December 16, 2020
Cytokine Signature in Schnitzler Syndrome: Proinflammatory Cytokine Production Associated to Th SuppressionMarie Masson Regnault, Eric Frouin, Isabelle Jéru, et al.Plos Pathogens|November 3, 2020
Veterinary trypanocidal benzoxaboroles are peptidase-activated prodrugsFederica Giordani, Daniel Paape, Isabel M Vincent, et al.Cardiovascular and Interventional Radiology|November 19, 2021
Evaluating the Effectiveness of Yttrium-90 Glass Microspheres in the Treatment of Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, and Metastatic Colorectal Cancer in Practice: Protocol for the Prospective PROACTIF Phase IV Registry Study in FranceEtienne Garin, Jean-Baptiste Pinaquy, Clement Bailly, et al.Molecular Cell|November 17, 2023
CDK4/6 inhibitor-mediated cell overgrowth triggers osmotic and replication stress to promote senescenceLisa Crozier, Reece Foy, Rozita Adib, et al.BMC Cancer|July 29, 2023
Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82)Angélique Vienot, Marion Jacquin, Magali Rebucci-Peixoto, et al.Liver Cancer|September 26, 2022
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic HepatocholangiocarcinomaElia Gigante, Christian Hobeika, Brigitte Le Bail, et al.Elife|March 2, 2021
Mapping immune variation and var gene switching in naive hosts infected with Plasmodium falciparumKathryn Milne, Alasdair Ivens, Adam J Reid, et al.Pageof 81